» Articles » PMID: 26483870

Detection of Hepatitis B Virus Infection: A Systematic Review

Overview
Journal World J Hepatol
Specialty Gastroenterology
Date 2015 Oct 21
PMID 26483870
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: To review published methods for detection of hepatitis B virus (HBV) infection.

Methods: A thorough search on Medline database was conducted to find original articles describing different methods or techniques of detection of HBV, which are published in English in last 10 years. Articles outlining methods of detection of mutants or drug resistance were excluded. Full texts and abstracts (if full text not available) were reviewed thoroughly. Manual search of references of retrieved articles were also done. We extracted data on different samples and techniques of detection of HBV, their sensitivity (Sn), specificity (Sp) and applicability.

Results: A total of 72 studies were reviewed. HBV was detected from dried blood/plasma spots, hepatocytes, ovarian tissue, cerumen, saliva, parotid tissue, renal tissue, oocytes and embryos, cholangiocarcinoma tissue, etc. Sensitivity of dried blood spot for detecting HBV was > 90% in all the studies. In case of seronegative patients, HBV DNA or serological markers have been detected from hepatocytes or renal tissue in many instances. Enzyme linked immunosorbent assay and Chemiluminescent immunoassay (CLIA) are most commonly used serological tests for detection. CLIA systems are also used for quantitation. Molecular techniques are used qualitatively as well as for quantitative detection. Among the molecular techniques version 2.0 of the CobasAmpliprep/CobasTaqMan assay and Abbott's real time polymerase chain reaction kit were found to be most sensitive with a lower detection limit of only 6.25 IU/mL and 1.48 IU/mL respectively.

Conclusion: Serological and molecular assays are predominant and reliable methods for HBV detection. Automated systems are highly sensitive and quantify HBV DNA and serological markers for monitoring.

Citing Articles

Detection technology and clinical applications of serum viral products of hepatitis B virus infection.

Liu Y, Wu D, Zhang K, Ren R, Liu Y, Zhang S Front Cell Infect Microbiol. 2024; 14:1402001.

PMID: 39035352 PMC: 11257880. DOI: 10.3389/fcimb.2024.1402001.


cccDNA-Targeted Drug Screen Reveals a Class of Antihistamines as Suppressors of HBV Genome Levels.

Ren E, Zhuo N, Goh Z, Bonne I, Malleret B, Ko H Biomolecules. 2023; 13(10).

PMID: 37892121 PMC: 10604930. DOI: 10.3390/biom13101438.


Comparative prevalence of hepatitis B virus infection among pregnant women accessing free maternal care in a tertiary hospital in Ghana.

Antuamwine B, Herchel E, Mishio Bawa E PLoS One. 2022; 17(3):e0263651.

PMID: 35245287 PMC: 8896678. DOI: 10.1371/journal.pone.0263651.


Nanoparticle-Based Lateral Flow Biosensors Integrated With Loop-Mediated Isothermal Amplification for the Rapid and Visual Diagnosis of Hepatitis B Virus in Clinical Application.

Chen X, Wang S, Tan Y, Huang J, Yang X, Li S Front Bioeng Biotechnol. 2021; 9:731415.

PMID: 34595159 PMC: 8477041. DOI: 10.3389/fbioe.2021.731415.


Multiple Cross Displacement Amplification Linked with Nanoparticles-Based Lateral Flow Biosensor in Screening of Hepatitis B Virus in Clinical Application.

Chen X, Zhou Q, Dong S, Wang S, Liu R, Wu X Infect Drug Resist. 2021; 14:1219-1229.

PMID: 33790592 PMC: 8007573. DOI: 10.2147/IDR.S297645.


References
1.
Magnius L, Espmark A . A new antigen complex co-occurring with Australia antigen. Acta Pathol Microbiol Scand B Microbiol Immunol. 1972; 80(2):335-7. DOI: 10.1111/j.1699-0463.1972.tb00167.x. View

2.
Mendy M, Kirk G, van der Sande M, Jeng-Barry A, Lesi O, Hainaut P . Hepatitis B surface antigenaemia and alpha-foetoprotein detection from dried blood spots: applications to field-based studies and to clinical care in hepatitis B virus endemic areas. J Viral Hepat. 2005; 12(6):642-7. DOI: 10.1111/j.1365-2893.2005.00641.x. View

3.
Sun S, Meng S, Zhang R, Zhang K, Wang L, Li J . Development of a new duplex real-time polymerase chain reaction assay for hepatitis B viral DNA detection. Virol J. 2011; 8:227. PMC: 3116493. DOI: 10.1186/1743-422X-8-227. View

4.
Yao C, Zhu T, Tang J, Wu R, Chen Q, Chen M . Hybridization assay of hepatitis B virus by QCM peptide nucleic acid biosensor. Biosens Bioelectron. 2007; 23(6):879-85. DOI: 10.1016/j.bios.2007.09.003. View

5.
ROBINSON W, Clayton D, Greenman R . DNA of a human hepatitis B virus candidate. J Virol. 1974; 14(2):384-91. PMC: 355524. DOI: 10.1128/JVI.14.2.384-391.1974. View